Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis

Metastasis accounts for approximately 90% of breast cancer-related deaths. Therefore, novel approaches which prevent or control breast cancer metastases are of significant clinical interest. Interleukin-12 (IL-12)-based immunotherapies have shown promise in controlling metastatic disease, yet modest...

Full description

Saved in:

Bibliographic Details
Published in:	Oncoimmunology
Main Authors:	Vo, Jimmy LN, Yang, Lirong, Kurtz, Samantha L, Smith, Sean G, Koppolu, Bhanu prasanth, Ravindranathan, Sruthi, Zaharoff, David A
Format:	Artigo
Language:	Inglês
Published:	Taylor & Francis 2015
Subjects:	Original Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4352958/ https://ncbi.nlm.nih.gov/pubmed/25964864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.968001
Tags:	Add Tag No Tags, Be the first to tag this record!

Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis

Similar Items